China National Accord Medicines Corporation Ltd. (SZSE:000028) agreed to acquire Foshan Nanhai Medical Company Group Company Ltd from Sinopharma Holdings for approximately CNY 580 million on January 4, 2017. China National Accord Medicines Corporation Ltd. will issue shares as consideration. In related transaction, China National Accord Medicines Corporation Ltd. agreed to acquire Guoda Drugstores, Guangdong Oriental New & Special Drugs Corporation and 51% stake in Sinopharm Guangdong Nanfang Foreign Trade Company from Sinopharma Holdings. China National Accord Medicines Corporation Ltd. will issue a total of 55.058 million shares to Sinopharma Holdings for the acquisitions. Sun Jiemin, Peng Jie and Hou Xiaoli of Beijing Tianjian Xingye Assets Appraisal Co., Ltd and Quan Zhongguang, Jiang Shubao and Yao Yongjun of Beijing Zhonghua China Assets Appraisal Co., Ltd. acted as assets assessment agencies for China National Accord Medicines Corporation Ltd. China National Accord Medicines Corporation Ltd. (SZSE:000028) completed the acquisition of Foshan Nanhai Medical Company Group Company Ltd from Sinopharma Holdings on January 4, 2018.